20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in normal renal function
HD                     :Unlikely to be dialysed. Dose as in normal renal function
HDF/high flux   :Unlikely to be dialysed. Dose as in normal renal function
CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Heparin: avoid concomitant use with high dose heparin
Thrombolytic therapy: avoid for 3 days before administering drotrecoginOral anticoagulants, antiplatelets: avoid for 7 days before administering drotrecogin
ADMINISTRATION
Reconstition
Water for injection
Route
IV infusion
Rate of Administration
24 micrograms/kg/hour
Comments
Further dilute with sodium chloride 0.9% to a concentration of 100–200 mcg/mLMinimum volume: 20 mg in 50 mL. (UK Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3rd Edition, 2006)
OTHER INFORMATION
No anticoagulation is required for haemofiltration as the drotrecogin acts as an anticoagulantCan be started 12 hours after major invasive procedures or surgeryClearance is reduced by 30% in renal impairment but no dose reduction is required Has a short half-life of 13 minutes and a β-half-life of 1.6 hours